ATE.TO
Antibe Therapeutics Inc
Price:  
0.30 
CAD
Volume:  
160,906.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ATE.TO WACC - Weighted Average Cost of Capital

The WACC of Antibe Therapeutics Inc (ATE.TO) is 7.6%.

The Cost of Equity of Antibe Therapeutics Inc (ATE.TO) is 11.45%.
The Cost of Debt of Antibe Therapeutics Inc (ATE.TO) is 5.00%.

Range Selected
Cost of equity 8.80% - 14.10% 11.45%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.3% - 8.9% 7.6%
WACC

ATE.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 1.11 1.64
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.80% 14.10%
Tax rate 25.90% 26.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.3% 8.9%
Selected WACC 7.6%